1. Home
  2. PRPO

PRPO

Precipio Inc.

Logo Precipio Inc.

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

as 04-22-2024 10:32am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Founded: N/A Country:
United States
United States
Employees: N/A City: OMAHA
Market Cap: 9.5M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 5.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.51 EPS Growth: N/A
52 Week Low/High: $4.75 - $15.42 Next Earning Date: 05-10-2024
Revenue: $15,197,000 Revenue Growth: 61.46%
Revenue Growth (this year): 75.18% Revenue Growth (next year): N/A

Share on Social Networks: